Yizhuo Gao

Yizhuo Gao

Auto-generated profile, based on publicly available information

Yizhuo Gao

Shengjing Hospital of China Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
YGYizhuo Gao
Yizhuo Gao
SWShibo Wei
Shibo Wei
YLYuchen Liu
Yuchen Liu
ZYZhenglun Yu
Zhenglun Yu
SZShanshan Zhan
Shanshan Zhan
DJDong Jia
Dong Jia
Background: Prioritization of management strategies in patients with normotensive acute pulmonary embolism is based on the identification of individuals at risk for early deterioration. This study aims to develop and validate a novel score for deterioration prediction using clinical‐imaging features. Methods: This is multicenter, prospective observational cohort study (AOAPECT [Adverse Outcomes in Acute Pulmonary Embolism patients using Computed Tomography pulmonary angiography] cohort, NCT05098769). Registered‐enrolled patients with normotensive acute pulmonary embolism were collected consecutively from 5 centers across China. Derivation set was established from 2 centers, while local and nonlocal external validation sets were derived from the remaining 3 centers. The end point was pulmonary embolism‐related deterioration within 30 days after admission. Deterioration‐related candidate predictors consisted of clinical, laboratory and computed tomography pulmonary angiography parameters were screened and then split into dichotomous values. The predictive score was conducted by a multivariable logistics regression and validated. Score performances were quantified using the area under the receiver operating characteristic curve. Results: Of 3310 enrolled patients including 1 derivation (n=2061) and 2 validation sets (n=969 and 280), 272 patients (8.2%) experienced deterioration. In the derivation set, an increased risk of deterioration was observed with right to left ventricle diameter ratio ≥1.2, appearance of pulmonary vein sign on computed tomography pulmonary angiography, and heart rate ≥110 beats/min. When at least 2 out of 3 items were positive, patients were assigned to the high‐risk deterioration group. This PE‐RPH score revealed good discrimination to deterioration in derivation and validation sets (area under the receiver operating characteristic curve, 0.82, 0.82, and 0.80). Conclusions: This PE‐RPH score incorporating 2 computed tomography pulmonary angiography parameters and heart rate may help predict the deterioration risk in patients with normotensive acute pulmonary embolism. REGISTRATION: https://clinicaltrials.gov ; identifier: NCT05098769.

16 September 2021 in Expert Review of Vaccines
Verified
Journal Article
Closed access
YFYongliang Feng
Yongliang Feng
YTYao Tian
Yao Tian
YGYizhuo Gao
Yizhuo Gao
HLHong Li
Hong Li
SDShuang Dong
Shuang Dong
SWSuping Wang
Suping Wang
We evaluated the safety and immunogenicity of four doses of 20 or 60 µg, and the immunogenicity and compliance of the short-term vaccination regimen (0, 1, and 2 months) among patients receiving MM...

1 August 2021 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
YGYizhuo Gao
Yizhuo Gao
NWNa Wang
Na Wang
YLYuhua Li
Yuhua Li
HHHaofeng Huang
Haofeng Huang
DJDong Jia
Dong Jia